{"entity":{"type":"insider","cik":"0001708764","url":"/insider/0001708764","json_url":"/insider/0001708764.json","name":"Franchini Indrani Lall","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":9,"first":"2018-02-08","last":"2024-02-29","span_basis":"filed_date"},"name_variants":[{"name":"Franchini Indrani Lall","source":"filing","n_filings":9,"first_seen":"2018-02-08","last_seen":"2024-02-29"}],"transactions":[{"id":2493390,"accession":"0001735276-24-000016","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001735276-24-000016","line_url":"/filing/0001735276-24-000016","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001708764","owner_name":"Franchini Indrani Lall","owner_display_name":"Franchini Indrani Lall","owner_url":"/insider/0001708764","role":"Officer (EVP, CLO & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CLO & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CLO & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":329.0,"shares_display":"329","price_per_share":155.30243161094225,"price_display":"155.30","price_state":"stated","total_value":51094.5,"total_display":"51,094.50","total_whole":"51,095","shares_owned_after":4320.0,"shares_owned_after_display":"4,320","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-28","filed_date":"2024-02-29","scope":"insider","n_lines":5},{"id":2616074,"accession":"0001735276-24-000002","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001735276-24-000002","line_url":"/filing/0001735276-24-000002","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001708764","owner_name":"Franchini Indrani Lall","owner_display_name":"Franchini Indrani Lall","owner_url":"/insider/0001708764","role":"Officer (EVP, CLO & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CLO & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CLO & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1591.0,"shares_display":"1,591","price_per_share":170.99311125078566,"price_display":"170.99","price_state":"stated","total_value":272050.04,"total_display":"272,050.04","total_whole":"272,050","shares_owned_after":3853.0,"shares_owned_after_display":"3,853","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-02-05","scope":"insider","n_lines":3},{"id":7984455,"accession":"0001735276-23-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001735276-23-000038","line_url":"/filing/0001735276-23-000038#line-1","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001708764","owner_name":"Franchini Indrani Lall","owner_display_name":"Franchini Indrani Lall","owner_url":"/insider/0001708764","role":"Officer (EVP, CLO & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CLO & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CLO & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":210.0,"price_display":"210.00","price_state":"stated","total_value":735000.0,"total_display":"735,000.00","total_whole":"735,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-06","filed_date":"2023-04-10","scope":"insider"},{"id":8512402,"accession":"0001735276-23-000007","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-23-000007","line_url":"/filing/0001735276-23-000007","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001708764","owner_name":"Franchini Indrani Lall","owner_display_name":"Franchini Indrani Lall","owner_url":"/insider/0001708764","role":"Officer (EVP, CLO & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CLO & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CLO & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1675.0,"shares_display":"1,675","price_per_share":226.0074686567164,"price_display":"226.01","price_state":"stated","total_value":378562.51,"total_display":"378,562.51","total_whole":"378,563","shares_owned_after":4091.0,"shares_owned_after_display":"4,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-02","filed_date":"2023-02-03","scope":"insider","n_lines":4},{"id":2992580,"accession":"0000899866-20-000065","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-20-000065","line_url":"/filing/0000899866-20-000065","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS, INC.","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001708764","owner_name":"Franchini Indrani Lall","owner_display_name":"Franchini Indrani Lall","owner_url":"/insider/0001708764","role":"Officer (EVP, Chief Compliance Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Compliance Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Compliance Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6853.0,"shares_display":"6,853","price_per_share":114.69155114548373,"price_display":"114.69","price_state":"stated","total_value":785981.2,"total_display":"785,981.20","total_whole":"785,981","shares_owned_after":29651.0,"shares_owned_after_display":"29,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-08","filed_date":"2020-06-09","scope":"insider","n_lines":2},{"id":8115184,"accession":"0000899866-19-000079","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-19-000079","line_url":"/filing/0000899866-19-000079#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS, INC.","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001708764","owner_name":"Franchini Indrani Lall","owner_display_name":"Franchini Indrani Lall","owner_url":"/insider/0001708764","role":"Officer (EVP, Chief Compliance Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Compliance Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Compliance Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":132.78,"price_display":"132.78","price_state":"stated","total_value":597510.0,"total_display":"597,510.00","total_whole":"597,510","shares_owned_after":29627.0,"shares_owned_after_display":"29,627","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-01","filed_date":"2019-07-02","scope":"insider"},{"id":6382123,"accession":"0000899866-18-000135","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-18-000135","line_url":"/filing/0000899866-18-000135#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS, INC.","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001708764","owner_name":"Franchini Indrani Lall","owner_display_name":"Franchini Indrani Lall","owner_url":"/insider/0001708764","role":"Officer (EVP, Chief Compliance Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Compliance Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Compliance Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2605.0,"shares_display":"2,605","price_per_share":118.13,"price_display":"118.13","price_state":"stated","total_value":307728.65,"total_display":"307,728.65","total_whole":"307,729","shares_owned_after":29304.0,"shares_owned_after_display":"29,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-28","filed_date":"2018-11-30","scope":"insider"},{"id":6619511,"accession":"0000899866-18-000104","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-18-000104","line_url":"/filing/0000899866-18-000104#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001708764","owner_name":"Franchini Indrani Lall","owner_display_name":"Franchini Indrani Lall","owner_url":"/insider/0001708764","role":"Officer (EVP, Chief Compliance Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Compliance Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Compliance Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1466.0,"shares_display":"1,466","price_per_share":118.53,"price_display":"118.53","price_state":"stated","total_value":173764.98,"total_display":"173,764.98","total_whole":"173,765","shares_owned_after":31909.0,"shares_owned_after_display":"31,909","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-08","filed_date":"2018-06-12","scope":"insider"},{"id":6492003,"accession":"0000899866-18-000039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-18-000039","line_url":"/filing/0000899866-18-000039#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001708764","owner_name":"Franchini Indrani Lall","owner_display_name":"Franchini Indrani Lall","owner_url":"/insider/0001708764","role":"Officer (EVP, Chief Compliance Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Compliance Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Compliance Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1459.0,"shares_display":"1,459","price_per_share":116.31,"price_display":"116.31","price_state":"stated","total_value":169696.29,"total_display":"169,696.29","total_whole":"169,696","shares_owned_after":25031.0,"shares_owned_after_display":"25,031","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-08","filed_date":"2018-02-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001178670","name":"ALNYLAM PHARMACEUTICALS, INC.","url":"/issuer/0001178670","role":"Officer (EVP, CLO & Secretary)","n_filings":4,"first_seen":"2023-02-03","last_seen":"2024-02-29"},{"type":"issuer","type_label":"ISSUER","cik":"0000899866","name":"ALEXION PHARMACEUTICALS, INC.","url":"/issuer/0000899866","role":"Officer (EVP, Chief Compliance Officer)","n_filings":5,"first_seen":"2018-02-08","last_seen":"2020-06-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001708764","retrieved_at":"2026-08-26T02:29:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}